Proteomics-based phenotypic classification of non-smallcell lung cancer

被引：0
|
作者：
Berkovska, O. [1 ]
Mermelekas, G. [1 ]
Orre, L. [1 ]
Lehtio, J. [1 ]
机构：
[1] Karolinska Inst, Oncol Pathol, Stockholm, Sweden
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1292
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2264P
引用
收藏
页码：S1163 / S1164
页数：2
相关论文
共 50 条
  • [31] PhaseIIStudy ofLow-DoseAfatinib Maintenance Treatment Among Patients withEGFR-Mutated Non-SmallCell Lung Cancer: North Japan Lung Cancer Study Group Trial 1601 (NJLCG1601)
    Nakamura, Atsushi
    Tanaka, Hisashi
    Saito, Ryota
    Suzuki, Aya
    Harada, Toshiyuki
    Inoue, Sumito
    Yamada, Toru
    Nakagawa, Taku
    Jingu, Daisuke
    Sugawara, Shunichi
    ONCOLOGIST, 2020, 25 (10): : E1451 - E1456
  • [32] Real-WorldTreatment Patterns andProgression-FreeSurvival Associated with Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitor Therapies forALK plus Non-SmallCell Lung Cancer
    Jahanzeb, Mohammad
    Lin, Huamao M.
    Pan, Xiaoyun
    Yin, Yu
    Wu, Yanyu
    Nordstrom, Beth
    Socinski, Mark A.
    ONCOLOGIST, 2020, 25 (10): : 867 - 877
  • [33] A proteomics-based biomarker discovery platform for predicting clinical response to immune checkpoint inhibitor therapy in non-small cell lung cancer
    Harel, Michal
    Khononov, Irena
    Issler, Eran
    Lahav, Coren
    Fremder, Ella
    Jacob, Eyal
    Dahan, Nili
    Raviv, Ziv
    Shkedy, Avishag
    Jacob, Reema
    Dicker, Adam
    Bar, Haim
    Sharon, Ofer
    Shaked, Yuval
    CANCER RESEARCH, 2020, 80 (16)
  • [34] Proteomics-based target identification of natural products affecting cancer metabolism
    Muroi, Makoto
    Osada, Hiroyuki
    JOURNAL OF ANTIBIOTICS, 2021, 74 (10): : 639 - 650
  • [35] Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev)
    Pastina, Pierpaolo
    Nardone, Valerio
    Botta, Cirino
    Croci, Stefania
    Tini, Paolo
    Battaglia, Giuseppe
    Ricci, Veronica
    Cusi, Maria Grazia
    Gandolfo, Claudia
    Misso, Gabriella
    Zappavigna, Silvia
    Caraglia, Michele
    Giordano, Antonio
    Aldinucci, Donatella
    Tassone, Pierfrancesco
    Tagliaferri, Pierosandro
    Pirtoli, Luigi
    Correale, Pierpaolo
    ONCOTARGET, 2017, 8 (44) : 75904 - 75913
  • [36] Proteomics-based identification of anti-tumor autoantibodies in patients with non-small-cell lung cancers
    Fujimoto, Minoru
    He Ping
    Serada, Satoshi
    Iwahori, Kota
    Naka, Tetsuji
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S905 - S905
  • [37] A Plasma Proteomics-Based Model for Clinical Benefit Prediction in Small Cell Lung Cancer Patients Receiving Immunotherapy
    Gandara, D. R.
    Carbone, D. P.
    Dicker, A. P.
    Christopoulos, P.
    Puzanov, I.
    Jain, P.
    Farrugia, D.
    Brown, S.
    Moskovitz, M.
    Bar, J.
    Hassani, A.
    Chatterjee, A.
    Abu-Amna, M.
    Polychronis, A.
    Brewster, A.
    Lou, Y.
    VanderWalde, N. A.
    Gottfried, M.
    Lahav, C.
    Lowenthal, G.
    Sela, I.
    Harel, M.
    Elon, Y.
    Schneider, M. A.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S354 - S355
  • [38] Plasma proteomics-based identification of novel biomarkers in early gastric cancer
    Zhou, Bin
    Zhou, Zhe
    Chen, Yuling
    Deng, Haiteng
    Cai, Yunlong
    Rao, Xiaolong
    Yin, Yuxin
    Rong, Long
    CLINICAL BIOCHEMISTRY, 2020, 76 : 5 - 10
  • [39] Proteomics-based target identification of natural products affecting cancer metabolism
    Makoto Muroi
    Hiroyuki Osada
    The Journal of Antibiotics, 2021, 74 : 639 - 650
  • [40] Dissecting the Role of the Extracellular Matrix in Cancer Progression: A Proteomics-based Approach
    Naba, Alexandra
    Clauser, Karl
    Carr, Steven A.
    Hynes, Richard
    MOLECULAR & CELLULAR PROTEOMICS, 2014, 13 (08) : S53 - S53
12345